Events
For the past 29 years, PharmaVentures has acted as advisor on over 900 deal related projects covering licensing, mergers, acquisitions, divestments, and joint venture activities for companies world-wide
We have unrivalled strategic insight in the commercialisation and transaction of assets and companies in the pharmaceutical, biotech, medtech and diagnostics sectors. We have been trusted by major corporations, high growth biotechs and emerging companies to provide insight and advice to help these businesses achieve their strategic goals. Operating globally in M&A, licensing, divestments and fundraising, we have the skills and experience to help you drive your business forward.
PharmaVentures attends key conferences and meetings to discuss our services and we also attend events on behalf of our clients, promoting advisory mandates in M&A and licensing across the life science sector.
How To Meet Us
We often have opportunities that could be transformative to your business, especially with the optimal strategy and best execution.
Our team attending these events are available to speak with you about your own requirements. To book a meeting, email us at:
Upcoming Webinar
22nd June, 2021 / 4pm CET / 10am EST / 3PM BST
How is M&A Shifting the Pharma Manufacturing Landscape?
This webinar will examine the trends and developments driving deal-making in the current market.
Upcoming events
9-11 June 2021
BIO KOREA 2021
Dr Fintan Walton, Founder & CEO at PharmaVentures alongside Dr Adrian Dawkes, Managing Director and Luke Lee, Associate will be presenting.
10-11 & 14-18 June 2021
BIO-Digital 2021
Dr Adrian Dawkes, Managing Director & Stephen Waterman, Managing Director will be available for 1-1 meetings to discuss fundraising and partnering.
Find out more about PharmaVentures’ Korean Market Expertise
24 June 2021
SEOUL BIOHUB
Dr Adrian Dawkes, Managing Director and Luke Lee, Associate, will be presenting.
Recent events
19 May 2021
BIA Start-up Festival
Mark Andrews, Managing Director chaired a panel discussion and Dr Adrian Dawkes attended 1-1 meetings.
17-19 May 2021
BIO-Equity Europe
Mark Andrews, Managing Director attended this virtual event.
28-30 April 2021
Sachs Neuroscience Innovation Forum
Mark Andrews, Managing Director attended this virtual event.
10-15 April 2021
AACR Annual Meeting
Dr Adrian Dawkes, Managing Director, attended this virtual event.
22-25 March 2021
BIO-Europe Spring Digital 2021
Summer Park, Senior Business Development Director attended this virtual event.
11 March 2021
N-Site Expert Advice Clinic
Dr Adrian Dawkes, Managing Director attended this virtual event and took part in 1-1 meetings.
1-3 September 2020
Biotechgate Digital Partnering
Summer Park, Senior Business Development Director attended this virtual event.
PharmaVentures InSights:
The impact of conference cancellations on dealmaking
during the Covid-19 pandemic
Can Partnering Conference Cancellations Affect Dealmaking in 2020?
We all got used to the partnering conference circuit as a means to introduce the latest developments to potential partners. So now they are all temporarily suspended whilst we overcome the current global health challenge, how do you make sure your opportunities are still getting in front of your potential partners.
PharmaVentures has been successfully connecting buyers and sellers for over 28 years with and without partnering conferences.
PharmaVentures’ CEO, Dr. Fintan Walton talks about how PharmaVentures is continuing a business as usual approach for all of our clients.
Don’t hesitate to contact us to help you carry on dealmaking.